CENTOGENE News & Events Header Image Broschure

News

Stay up to date and read about our most recent milestones towards achieving CENTOGENE’s mission: To enable the cure of 100 rare diseases in 10 years.

Interested in receiving the latest news around the clock? Follow us on LinkedIn.

CENTOGENE Reports First-Quarter 2020 Financial Results and Corporate Progress

Cambridge, MA, USA & Rostock/Berlin, Germany, June 15, 2020 (Globe Newswire) – Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on…

Read more

CENTOGENE to Report First-Quarter 2020 Financial Results on June 15, 2020

Cambridge, MA, USA and Rostock/Berlin, Germany, June 8, 2020 (Globe Newswire) – Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on…

Read more

CENTOGENE Announces Changes in Senior Management Team

Cambridge, MA, USA and Rostock/Berlin, Germany, May 15, 2020 (Globe Newswire) - Centogene (Nasdaq: CNTG), a commercial-stage company focused on rare…

Read more

CENTOGENE Expands Senior Leadership Team with Newly Appointed Senior Vice President Communication and Marketing

Cambridge, MA, USA & Rostock/Berlin, Germany, May 6, 2020 (Globe Newswire) ─ CENTOGENE (Nasdaq: CNTG), a commercial-stage company focused on rare…

Read more

CENTOGENE Reports Financial Results for Full Year 2019 and Highlights Recent Progress

Cambridge, MA, USA & Rostock, Berlin, GERMANY, April 23, 2020 – Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases…

Read more

CENTOGENE Announces Opening of Laboratory in Hamburg, Germany

Cambridge, MA, USA & Rostock/Berlin, Germany, April 15, 2020 (Globe Newswire) – CENTOGENE (Nasdaq: CNTG), a commercial-stage company focused on rare…

Read more

CENTOGENE Smartphone App myLSDapp Now Available in Spanish

Gaucher Disease Monitoring and Treatment Management

Cambridge, MA USA & Rostock, Germany, March 24, 2020 – CENTOGENE (Nasdaq: CNTG) today announced…

Read more

CENTOGENE Announces Changes in Supervisory Board

Cambridge, MA, USA and Rostock/Berlin, Germany, March 17, 2020 (Globe Newswire) – CENTOGENE N.V. (Nasdaq: CNTG), a commercial-stage company focused on…

Read more

CENTOGENE Announces Departure of Dirk Ehlers From Executive Board

Cambridge, MA, USA and Rostock/Berlin, Germany, March 9, 2020 – CENTOGENE (Nasdaq: CNTG) ─ The Company today announced that Dr. Dirk H. Ehlers, COO…

Read more

CENTOGENE, OMER, and ALIBER’s Rare Disease Day Event in Mexico City 2020: Inspiring Insights on Patient Organizations’ Contributions to Solutions for Patients in Latin America

Mexico City, February 29, 2020- More than 300 participants gathered on Saturday at Hotel Marriot Reforma in Mexico City to raise awareness about rare…

Read more

For Further Inquiries Please Contact

Press Contact

Melissa Hall

Corporate Communications

Email Us

Downloads

Here you can find forms, brochures, flyer and information sheets for download (PDF) about the broad genetic testing product and service portfolio of CENTOGENE.

Downloads